NR 325 exam 1 study test guide
Urine Specific Gravity - ANS 1.010-1.030
Creatinine - ANS 0.6-1.2
BUN - ANS 10-20 mg/dL
SIADH treatment - ANS Fluid restriction, IV hypertonic saline, conivaptan/tolvaptan,
demeclocycline
Diabetes insipidus (DI) - ANS antidiuretic hormone (ADH) is not secreted, or there is a
resistance of the kidney to ADH
Diabetes Inspidus treatment - ANS Hypotonic solution, giving in what we are putting out
Vasopressin/Desmopressin
Carbamazepine
Antidiuretic hormone (ADH) - ANS Hormone produced by the neurosecretory cells in the
hypothalamus that stimulates water reabsorption from kidney tubule cells into the blood and
vasoconstriction of arterioles.
Serum Osmolality - ANS 285-295 mOsm/kg
Serum osmolality in SIADH - ANS <270 mOsm/L
Specific gravity in SIADH - ANS 1.036
Serum osmality in DI - ANS 320, syrup
sodium in DI - ANS 160
sodium in SIADH - ANS 125
Hypernatremia nursing interventions - ANS Monitor fluid intake and output.
Vital signs: tachycardia, tachypnea
Assessment of mucous membranes
Monitor behavior changes (e.g., restlessness, disorientation).
Monitor laboratory findings (e.g., serum sodium).
Encourage fluids as ordered.
Monitor diet as ordered (e.g., restrict intake of salt and foods high in sodium).
, diabetes inspidous - ANS correcting low volume and low blood pressure
thyroid gland - ANS produces hormones that regulate metabolism, body heat, and bone
growth
myexedema coma - ANS progresses from hypothyroidism and shows decreases in mental
status
thyroid storm - ANS increased temp, pulse and HTN
clinical manifestations of hyperthyroidism - ANS Young to middle-aged women
Changes in behavior, insomnia, restlessness, tremor, irritability, palpitations, heat intolerance,
diaphoresis, inability to concentrate that interferes with work performance
Increased basal metabolic rate leads to weight loss, although appetite and dietary intake
increase
Amenorrhea/scant menses
hyperthyroidism causes - ANS excess iodine, medications, graves disease, autoimmune
disease, radiation exposure, stress
hyperthyroidism diagnostic tests - ANS -T3 and T4 level
-TSH level
-Serum calcium (elevated)
-Serum phosphorus (low)
-RAI (radioactive iodine) uptake test
hyperthyroidism treatment - ANS methimazole, propylthiouracil (preferred in pregnancy)
Radioactive iodine, Beta blockers
Insulin types - ANS Rapid-acting (clear) , Short-acting (clear), Intermediate (cloudy), Long
acting , Combinations
rapid-acting insulin - ANS Lispro (Humalog)
short-acting insulin - ANS Regular (Humulin R, Novolin R)
intermediate acting insulin - ANS NPH (Humulin N, Novolin N)
long acting insulin - ANS Glargine (Lantus)
Rapid acting insulin onset - ANS 10-30 minutes
Urine Specific Gravity - ANS 1.010-1.030
Creatinine - ANS 0.6-1.2
BUN - ANS 10-20 mg/dL
SIADH treatment - ANS Fluid restriction, IV hypertonic saline, conivaptan/tolvaptan,
demeclocycline
Diabetes insipidus (DI) - ANS antidiuretic hormone (ADH) is not secreted, or there is a
resistance of the kidney to ADH
Diabetes Inspidus treatment - ANS Hypotonic solution, giving in what we are putting out
Vasopressin/Desmopressin
Carbamazepine
Antidiuretic hormone (ADH) - ANS Hormone produced by the neurosecretory cells in the
hypothalamus that stimulates water reabsorption from kidney tubule cells into the blood and
vasoconstriction of arterioles.
Serum Osmolality - ANS 285-295 mOsm/kg
Serum osmolality in SIADH - ANS <270 mOsm/L
Specific gravity in SIADH - ANS 1.036
Serum osmality in DI - ANS 320, syrup
sodium in DI - ANS 160
sodium in SIADH - ANS 125
Hypernatremia nursing interventions - ANS Monitor fluid intake and output.
Vital signs: tachycardia, tachypnea
Assessment of mucous membranes
Monitor behavior changes (e.g., restlessness, disorientation).
Monitor laboratory findings (e.g., serum sodium).
Encourage fluids as ordered.
Monitor diet as ordered (e.g., restrict intake of salt and foods high in sodium).
, diabetes inspidous - ANS correcting low volume and low blood pressure
thyroid gland - ANS produces hormones that regulate metabolism, body heat, and bone
growth
myexedema coma - ANS progresses from hypothyroidism and shows decreases in mental
status
thyroid storm - ANS increased temp, pulse and HTN
clinical manifestations of hyperthyroidism - ANS Young to middle-aged women
Changes in behavior, insomnia, restlessness, tremor, irritability, palpitations, heat intolerance,
diaphoresis, inability to concentrate that interferes with work performance
Increased basal metabolic rate leads to weight loss, although appetite and dietary intake
increase
Amenorrhea/scant menses
hyperthyroidism causes - ANS excess iodine, medications, graves disease, autoimmune
disease, radiation exposure, stress
hyperthyroidism diagnostic tests - ANS -T3 and T4 level
-TSH level
-Serum calcium (elevated)
-Serum phosphorus (low)
-RAI (radioactive iodine) uptake test
hyperthyroidism treatment - ANS methimazole, propylthiouracil (preferred in pregnancy)
Radioactive iodine, Beta blockers
Insulin types - ANS Rapid-acting (clear) , Short-acting (clear), Intermediate (cloudy), Long
acting , Combinations
rapid-acting insulin - ANS Lispro (Humalog)
short-acting insulin - ANS Regular (Humulin R, Novolin R)
intermediate acting insulin - ANS NPH (Humulin N, Novolin N)
long acting insulin - ANS Glargine (Lantus)
Rapid acting insulin onset - ANS 10-30 minutes